NCT05887895View on ClinicalTrials.gov

To Compare the Pharmacokinetics and Pharmacodynamics of HR20014, INS068 and INS062 After Single Subcutaneous Injection in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 23, 2023

Primary Completion Date

July 18, 2023

Study Completion Date

July 18, 2023

Conditions
Diabetes
Interventions
DRUG

INS062 injection、INS068 injection、HR20014 injection

"INS062 injection：A single dose of 0.4 DU/kg is administered to healthy subjects.~INS068 injection：A single dose of 0.4 U/kg is administered to healthy subjects.~HR20014 injection：A single dose of 0.4 U/kg is administered to healthy subjects."

Trial Locations (1)

230601

The second affiliated hospital of Anhui Medical University, Hefei

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT05887895 - To Compare the Pharmacokinetics and Pharmacodynamics of HR20014, INS068 and INS062 After Single Subcutaneous Injection in Healthy Subjects | Biotech Hunter | Biotech Hunter